-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622. Lymphomas: Translational–Non-Genetic: Poster II

Symposia: Lymphomas: Translational–Non-Genetic Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Hosna Baniadam, MSc1*, Tobias Wertheimer2,3*, Stefanie Reisenauer4*, Odit Gutwein5*, Thi Huong Lan Do, MSc6*, Marcel Pohly7*, Ester Cannizzaro, PhD8*, Lukas Rindlisbacher9*, Stefanie Kreutmair9*, Susanne Unger10*, Can Ulutekin11*, Marijne Vermeer11*, Colin Sparano12*, Andreas Moor13*, Wolfgang Huber14*, Burkhard Becher15* and Thorsten Zenz16,17

1European Molecular Biology Laboratory, Heidelberg, Germany
2Institute for Experimental Immunology, University of Zurich, Zurich, NY, Switzerland
3Department for Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
4University Hospital Zurich, Zurich, Switzerland
5University Hospital of Zurich, Zurich, Switzerland
6Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Zurich, Switzerland
7University Hospital Zurich, Switzerland, Zurich, CHE
8University Hospital of Zürich, Zürich, AL, CHE
9University of Zurich, Zurich, Switzerland
10University of Zurich, Zurich, AL, CHE
11Institute of experimental immunology, University of Zurich, Zurich, Switzerland
12Institute of Experimental Immunology, Zurich, CHE
13Dep. of Biosystems Science and Eng., ETH Zurich, Zurich, Switzerland
14Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
15University of Zurich, Zurich, CHE
16INTeRCepT Consortium, The LOOP Zurich Medical Research Center, Zurich, Switzerland
17Department of Medical Oncology and Hematology, University Hospital Zurich, Zürich, Switzerland

Wenzhuo Zhuang, MD, PhD1*, Meifang Zhao2* and Bingzong Li, MD, PhD2

1Suzhou Medical College of Soochow University, Suzhou, China
2The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

Joseph Lownik, MD, PhD1, Larry Milshteyn, BS2*, Anton Villamejor2*, Jude Canon3* and Akil Merchant, MD2

1Cedars-Sinai Medical Center, Los Angeles, CA
2Cedars-Sinai Medical Cetner, Los Angeles, CA
3Oncovalent Therapeutics, Thousand Oaks

Li Li*, Wenjing Yang*, Ruyu Ye*, Yuanyuan Pan*, Qi Zhang*, Bo Tang* and Xiaobo Wang*

The Second Hospital of Dalian Medical University, Dalian, China

Alexandra Traverse-Glehen, MD, PhD1*, Laurent Martin, MD, PhD2*, Camille Laurent, MD, PhD3*, Peggy Dartigues, MD4*, Barbara Burroni, MD5*, Diane Damotte, MD, PhD5*, Marie Parrens, MD, PhD6*, Herve Ghesquieres, MD, PhD7*, Marguerite Fournier8*, Salim Kanoun, MD9*, Anne Ségolène Cottereau, MD10*, Marc Andre, MD11*, Cédric Rossi, MD, PhD12,13 and René-Olivier Casasnovas, MD14*

1Service de Pathologie Sud, Hospices Civils de Lyon, Pierre-Bénite, France
2Department of Pathology, CHU DIJON, Dijon, France
3Institut Universitaire du Cancer , Oncopole, Toulouse, France
4Department of Pathology, Gustave Roussy, Villejuif, France
5Department of Pathology, Hôpital Cochin, Paris, France
6Department of Pathology, University Bordeaux Hospital, Pessac, France
7Hematology Department, Hopital Lyon Sud - HCL, Lyon, France
8LYSARC, Pierre-Benite, France
9Nucear Medicine Department, IUCT Oncopole, Toulouse, France
10Nuclear Medicine Department, Hopital Cochin, Paris, France
11Department of Hematology, Clinique de Mont-Godinne, Yvoir, Belgium
12Stanford University, Stanford, CA
13CHU Dijon, Dijon, France
14Hematology Department, CHU Dijon, Dijon, France

Masahiro Sekimizu, MD, PhD1*, Tomoyuki Watanabe2*, Tetsuya Mori, MD, PhD3*, Ryoji Kobayashi, MD4*, Atsuko Nakazawa5*, Akiko M Saito, MD, PhD6*, Tetsuya Takimoto7*, Masahito Tsurusawa, MD8*, Keizo Horibe, MD, PhD9*, Yasuhiro Okamoto, MD, PhD10 and Shosuke Sunami, MD, PhD11*

1NHO Nagoya Medical Center, Nagoya, Japan
2Aichi Gakuin University, Nisshin, JPN
3Department of Pediatrics, St. Marianna University School of Medicine, Kanagawa, JPN
4Sappro Hokuyu Hospital, Sapporo, JPN
5Saitama Children’s Medical Center, Saitama, JPN
6Clinical Research Center, NHO Nagoya Medical Center, Nagoya, JPN
7National Center for Child Health and Development, Tokyo, Japan
8Aichi Medical University, Nagakute, JPN
9NHO Nagoya Medical Center, Nagoya, JPN
10Kagoshima University, Kagoshima, JPN
11Japanese Red Cross Narita Hospital, Narita, JPN

Tingting Jiang*, Yu Peng*, Xinyi Tang*, Shuang Chen*, Zailin Yang* and Yao Liu, PhD, MD

Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China

Beatriz Wills, MD1, Roni Shouval, MD, PhD2, Jessica R. Flynn, MS3*, Sean M. Devlin, PhD4*, Allison Parascondola, MPH5*, Amethyst Saldia, BS5*, Brandon S. Imber, MD, MA6, Ana Alarcon Tomas, MD7*, Ivan Landego, MD5*, Richard J. Lin, MD, PhD2, Michael Scordo2, Parastoo Bahrami Dahi, MD8*, Gunjan L. Shah9, Andrew Ip, MD MSc10, Lori A Leslie11*, Hyung Chan Suh, MD, PhD10, Gilles Salles, MD, PhD1, Miguel-Angel Perales, MD12 and Maria Lia Palomba, MD13

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York
4Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
5Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
7Division of Hematology and Hemotherapy, Hospital General Universitario Gregorio Maranon, Madrid, Spain
8Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
9Memorial Sloan Kettering Cancer Center, New York, NY
10Hackensack University Medical Center, Hackensack, NJ
11John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
12Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
13Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York

Maare Arffman, MSc1,2*, Leo Meriranta, MD2,3*, Judit Mészáros Jørgensen, MD, PhD4*, Harald Holte, MD, PhD5, Øystein Fluge, MD, PhD6*, Peter de Nully Brown, MD, PhD7, Kristina Drott, MD, PhD8*, Sirkku Jyrkkiö, MD, PhD9*, Suvi-Katri Leivonen, PhD2,3 and Sirpa Leppä, Professor2,3

1University of Helsinki, Helsinki, AL, Finland
2Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3University of Helsinki, Helsinki, Finland
4Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
5Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway
6Haukeland University Hospital, Bergen, Norway
7Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
8Skåne University Hospital, Lund, Sweden
9Turku University Hospital, Turku, Finland

Shengqin Su1*, Ajay Subramanian2*, Timothy Flerlage, MD3*, Jamie E. Flerlage, MD, MS3, Stefan K. Alig, MD4, Everett J. Moding, MD, PhD2*, Richard T. Hoppe, MD2, Ranjana H. Advani, MD4, Yasodha Natkunam, MD, PhD5, Ash A. Alizadeh, MD, PhD4 and Michael S. Binkley, MD, MS2*

1Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
2Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
3Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
4Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
5Department of Pathology, Stanford University School of Medicine, Stanford, CA

Koorosh Korfi, PhD1, Ailsa Christiansen, PhD2*, Zhiwen Jiang, PhD3*, Sabine Wilson, PhD4*, Samuel Tracy5*, Annika Blank, PhD6*, Sylvia Herter, PhD7*, Natalie Dimier, PhD8*, Bruno Gomes, PhD3*, Pablo Umana, PhD9, Herve Ghesquieres, MD, PhD10*, Roch Houot11*, Fritz Offner, MD12, Harriet Walter13*, Nancy L. Bartlett, MD14, Guillaume Cartron, MD, Ph-D15*, Michael Dickinson, MBBS, D. Med Sci, FRACP, FRCPA16, William Townsend, MD, FRCPath, MRCP17*, Giuseppe Gritti18*, Francesc Bosch Albareda, MD, PhD19, Franck Morschhauser, MD PhD20, Martin Hutchings, MD, PhD21*, Carmelo Carlo-Stella, Prof MD22 and Katharina Lechner23*

1Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche, Schlieren, -- Select, Switzerland
2A4P Consulting Ltd, Sandwich, United Kingdom
3Roche Pharma Research and Early Development, Roche Innovation Center Basel, Roche, Basel, Switzerland
4Roche Pharma Research and Early Development, Roche Innovation Center Basel, Roche, Basel, CHE
5Genentech Inc., South San Francisco, CA
6Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Roche, Zurich, Switzerland
7Roche Innovation Center Zurich, Roche, Schlieren, Switzerland
8Roche Innovation Center Welwyn, Roche, Welwyn, GBR
9Roche Innovation Center Zurich, Roche/Genentech, Schlieren, Switzerland
10University of Lyon, Lyon, FRA
11Centre Hospitalier Universitaire Rennes, Université de Rennes, Rennes Cedex, FRA
12Universitair Ziekenhuis Gent, Gent, Belgium
13University of Leicester and University Hospitals Leicester, Leicester, GBR
14Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
15Dept. Biological Hematology, Montpellier University Hospital Center, Montpellier, FRA
16Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
17King's College, London - Rayne Institute, London, GBR
18ASST Papa Giovanni XXIII, Bergamo, Italy
19Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
20CHRU de Lille, Hôpital Claude Huriez, Lille, Cedex, FRA
21Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
22IRCCS Humanitas Research Hospital, Humanitas University, ROZZANO, ITA
23Roche Pharma Research and Early Development, Roche Innovation Center Munich, Roche, Penzberg, Germany

Nicole Seifert1*, Sarah Reinke2*, Johanna Grund2*, Berit Müller-Meinhard2*, Andreas Engert, MD3*, Peter Borchmann4,5, Paul J Bröckelmann, MD3*, Michael Altenbuchinger1* and Wolfram Klapper2*

1Department of Medical Bioinformatics, University Medical Center Göttingen, Göttingen, Germany
2Department of Pathology, University Hospital Schleswig-Holstein, Kiel, DEU
3Department of Internal Medicine I, University Hospital of Cologne, Koeln, DEU
4German Hodgkin Study Group, Cologne, Germany
5Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany

Yassine Al Tabaa, MD, PhD, PharmD1*, Clément Bailly, MD, PhD2*, Xavier Pallard, MD, PhD3*, Anne Ségolène Cottereau, MD4*, Jérémie Tordo, MD5*, Pierre Sesques6*, Guillaume Cartron, MD, Ph-D7*, Roch Houot, MD, PhD8*, Roberta Di Blasi, MD, PhD9*, Salim Kanoun, MD10*, Caroline Milin, MD, PhD2*, Françoise Kraeber-Bodéré, MD, PhD2* and Laetitia Vercellino, MD, PhD11*

1Scintidoc Nuclear Medicine Center, Montpellier, France
2CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
3Nuclear Medicine Department, University Hospital, Nantes, France
4Nuclear Medicine Department, Hopital Cochin, Paris, France
5Hospices Civils De Lyon, Pierre-béNite, FRA
6CHU LYON SUD, PIERRE BENITE CEDEX, France
7Clinical Hematology Department, Montpellier University Hospital Center, Montpellier, France
8CHU de Rennes, Rennes, France
9Department of Hematology, Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis, University of Paris, PARIS, France
10Centre de Recherche Clinique de Toulouse, Team 9, Toulouse, France
11Nuclear Medicine Department, Hopital Saint Louis, Paris, France

Debra K. Czerwinski, BA1, Tanaya Shree, MD, PhD2, Sarah Haebe, MD3*, Shuyu Shi4*, Steven R Long, MD5*, Brock Martin, MD6* and Ronald Levy, MD1

1Stanford University School of Medicine, Stanford, CA
2Oregon Health and Science University, Portland, OR
3Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
4Dept. of Bioengineering, Schools of Engineering and Medicine, Stanford, CA
5Dept. of Pathology, UCSF, San Francisco, CA
6Dept. of Pathology, University of Louisville School of Medicine, Louisville, KY

Larry Milshteyn, BS1*, Joseph Lownik, MD, PhD2, Anton Villamejor1* and Akil Merchant, MD1

1Cedars-Sinai Medical Cetner, Los Angeles, CA
2Cedars-Sinai Medical Center, Los Angeles, CA

*signifies non-member of ASH